Trial intelligence / Profile preview

Raloxifene in men with chronic schizophrenia

IRCT201211211556N47Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of raloxifene in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Nov 2012; status: completed.

02

Drugs

raloxifene
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT201211211556N47.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201211211556N47.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call